Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 1.5 Years Prospective Study Designed to Delineate the Cause of the Thrombocytopathy in Gaucher Disease Patients

NCT01344096 is registered in ClinicalTrials.gov with Rabin Medical Center as lead sponsor.

NCT NCT01344096
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01344096 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 1.5 Years Prospective Study Designed to Delineate the Cause of the Thrombocytopathy in Gaucher Disease Patients
Lead sponsor
Rabin Medical Center
Phase
Observational
Overall status
Unknown status
Start date
October 31, 2010
Completion date
November 30, 2018
Enrollment
70 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

gaucher disease, thrombocytopathy